TARS - Tarsus Pharmaceuticals, Inc. - SEC Form 4 Insider Trading Screener

Manufactured Goods - Chemicals - Biological Products, (No Diagnostic Substances) - TARS (1819790)
General
Tickers
Insider
Sh Price $
Lqdty M$
Date
Filing Date
  
Trade Date
  
Filing Delay
N Days Ago
Transaction Filing
 P - Purchase
 S - Sale
 A - Grant
 D - Sale to Iss
 G - Gift
 F - Tax
 M - Option Ex
 X - Option Ex
 C - Cnv Deriv
 W - Inherited
No deriv Multiple Days
Traded K$
Own Chg %
Industry
Insider Title     Officer
    COB
    CEO
    Pres
    COO
    CFO
    GC
    VP
  Director
  10%own
  Other
Group by
Sort by
Max Results
Page
   clear

6 results. Finviz - SEC - Yahoo - Stockcharts - Tradingview
TCcnt1d1w1m6m

X

Filing Date

Trade Date

Ticker

Insider Name

Title

Trade Type  

Price

Qty

Owned

ΔOwn

Value

1d

1w

1m

6m

2021-05-07
TARSRtw Investments, LP10%S - Sale$29.98-450,0002,013,601-18%-$13,491,000
2021-04-14
TARSVivo Capital Ix, LLC10%S - Sale$30.37-4003,244,6350%-$12,148
D
2020-10-20
TARSFrazier Life Sciences Ix, L.P.10%P - Purchase$16.00+312,5001,917,157+19%+$5,000,000
D
2020-10-20
TARSHorowitz Limited Partnership VIII10%P - Purchase$16.00+184,3751,987,105+10%+$2,950,000
D
2020-10-20
TARSVivo Capital Ix, LLC10%P - Purchase$16.00+250,0003,245,035+8%+$4,000,000
D
2020-10-20
TARSTester Jason E.Dir, 10%P - Purchase$16.00+171,8751,949,331+10%+$2,750,000

AAmended filing
DDerivative transaction in filing (usually option exercise)
EError detected in filing
MMultiple transactions in filing; earliest reported transaction date and weighted average transaction price
S - SaleSale of securities on an exchange or to another person
S - Sale+OESale of securities on an exchange or to another person (after option exercise)
F - TaxPayment of exercise price or tax liability using portion of securities received from the company
P - PurchasePurchase of securities on an exchange or from another person
Return to top